Literature DB >> 11682517

Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.

S Silbert1, A L Barth, H S Sader.   

Abstract

The aim of this study was to assess the diversity and genomic variability of Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients being treated at a university hospital in Brazil. Ninety-seven isolates of P. aeruginosa from 43 CF patients were characterized by macrorestriction analysis of chromosomal DNA by pulsed-field gel electrophoresis (PFGE) and tested for susceptibility to 20 antimicrobial agents by broth microdilution. It was possible to evaluate single isolates from 20 patients and multiple isolates (two to seven) from 23 patients collected during a 22-month period. Among all of the unrelated patients, we detected only one pair of patients sharing a common strain. Among the 77 isolates from 23 patients who had multiple isolates analyzed, we identified 37 major types by PFGE, and five different colonization patterns were recognized. The isolates were susceptible to several antimicrobial agents, although consecutive isolates from the same patient may display differences in their susceptibilities. Mucoid isolates were more resistant (P < 0.001) than nonmucoid isolates to five antibiotics. Our results indicate that CF patients remain colonized by more than one strain of P. aeruginosa for long periods of time. In addition, the finding of several different genotypes in the same patient suggests that the colonizing strain may occasionally be replaced.

Entities:  

Mesh:

Year:  2001        PMID: 11682517      PMCID: PMC88474          DOI: 10.1128/JCM.39.11.3976-3981.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Molecular epidemiology of Pseudomonas aeruginosa from cystic fibrosis in Sicily: genome macrorestriction analysis and rapid PCR-ribotyping.

Authors:  A Agodi; A Sciacca; F Campanile; C Messina; M Barchitta; S Sciacca; S Stefani
Journal:  New Microbiol       Date:  2000-07       Impact factor: 2.479

2.  Microbial Pathogens Associated With Cystic Fibrosis: Special Focus on Pseudomonas aeruginosa.

Authors: 
Journal:  Braz J Infect Dis       Date:  1998-04       Impact factor: 1.949

3.  Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.

Authors:  L Saiman; F Mehar; W W Niu; H C Neu; K J Shaw; G Miller; A Prince
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

4.  Restriction enzyme and Southern hybridization analyses of Pseudomonas aeruginosa strains from patients with cystic fibrosis.

Authors:  J S Loutit; L S Tompkins
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1975-12

7.  Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp--a molecular-epidemiological study.

Authors:  K P Hunfeld; C Schmidt; B Krackhardt; H G Posselt; J Bargon; Y Yahaf; V Schäfer; V Brade; T A Wichelhaus
Journal:  Wien Klin Wochenschr       Date:  2000-04-07       Impact factor: 1.704

8.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.

Authors:  M J Struelens; V Schwam; A Deplano; D Baran
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.

Authors:  D Grothues; U Koopmann; H von der Hardt; B Tümmler
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

10.  Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings.

Authors:  N H Renders; M A Sijmons; A van Belkum; S E Overbeek; J W Mouton; H A Verbrugh
Journal:  Res Microbiol       Date:  1997-06       Impact factor: 3.992

View more
  9 in total

1.  Towards "molecular Esperanto" or the Tower of Babel? (the need for harmonization of techniques for genotyping clinical isolates of Pseudomonas aeruginosa isolated from patients with cystic fibrosis).

Authors:  John E Moore; Colin E Goldsmith; J Stuart Elborn; Philip G Murphy; Peter H Gilligan; Séamus Fanning; Graham Hogg
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 2.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.

Authors:  Mario Anthony; Barbara Rose; Mary Beard Pegler; Mark Elkins; Helen Service; Keerthi Thamotharampillai; Jason Watson; Michael Robinson; Peter Bye; John Merlino; Colin Harbour
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

4.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis.

Authors:  Duha Al-Zubeidi; Patrick G Hogan; Mary Boyle; Carey-Ann D Burnham; Stephanie A Fritz
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

5.  Characterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India.

Authors:  Gunjan Agarwal; Arti Kapil; Susheel Kumar Kabra; Bimal Kumar Das; Sada Nand Dwivedi
Journal:  BMC Microbiol       Date:  2005-07-21       Impact factor: 3.605

6.  In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.

Authors:  Tomasz Olszak; Paulina Zarnowiec; Wieslaw Kaca; Katarzyna Danis-Wlodarczyk; Daria Augustyniak; Pavel Drevinek; Anthony de Soyza; Siobhán McClean; Zuzanna Drulis-Kawa
Journal:  Appl Microbiol Biotechnol       Date:  2015-03-12       Impact factor: 4.813

7.  Molecular longitudinal tracking of Mycobacterium abscessus spp. during chronic infection of the human lung.

Authors:  Kaj M Kreutzfeldt; Paul R McAdam; Pauline Claxton; Anne Holmes; A Louise Seagar; Ian F Laurenson; J Ross Fitzgerald
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

8.  Comparison of the worldwide transmissible Pseudomonas aeruginosa with isolates from brazilian cystic fibrosis patients.

Authors:  Robson Souza Leão; Ana Paula D Carvalho-Assef; Alex Guerra Ferreira; Tânia Wrobel Folescu; Afonso Luís Barth; Tyrone Leslie Pitt; Elizabeth Andrade Marques
Journal:  Braz J Microbiol       Date:  2010-12-01       Impact factor: 2.476

9.  Genetic similarity of Burkholderia cenocepacia from cystic fibrosis patients.

Authors:  Luana Pretto; Fernanda de-Paris; Alice Beatriz Mombach Pinheiro Machado; Andreza Francisco Martins; Afonso Luís Barth
Journal:  Braz J Infect Dis       Date:  2013-01-01       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.